Finance entity
All 1 tracked stories fall under one category: economy. Bulk drugs and drug intermediates is most often covered alongside Drug formulations and biologicals, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window.
Last mentioned: 4d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: economy. Bulk drugs and drug intermediates is most often covered alongside Drug formulations and biologicals, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. At 5, the average consequence score sits below the same-window beat average of 5.4. Bulk drugs and drug intermediates appears in 1 tracked Finance story from August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 44 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bulk drugs and drug intermediates. Shared-story counts are live from our verified record — not editorial picks.
India's pharma exports grew 6.8% to $8.1B in Q1 FY27, with the US absorbing $2.5B at a 30.89% share — trade and earnings data that shapes the outlook for Indian healthcare exporters and investors.
Bulk drugs and drug intermediates is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
